Company
BioLargo Inc
OTCMKTS: BLGO
BioLargo Inc invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. The company accomplishes this by providing the capital, support, and expertise to expedite these disruptive technologies from "cradle" to "maturity". BioLargo monetizes through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. The company's patented technologies are all built to be best-in-class solutions to tough technical challenges, and they are backed up by world-class engineering and support services.
82 stories
BioLargo drops pet odor control product Pooph into Walmart stores across the US
Pooph is based on BioLargo's proprietary odor control technology and is being marketed by Ikigai Marketing Works LLC with a national advertising push
BioLargo boasts 3Q revenue growth of 111% to record $1.5 million
"Our strategy of growing by leveraging our core technology assets through channel partnerships is paying off," said CEO Dennis P Calvert
BioLargo subsidiary presents pilot program results at Canadian conference; shows up to 100% removal of contaminants from wastewater
Removal efficiency increased to between 84% and 100%, depending on the particular contaminant, at the municipal wastewater treatment plant near Montreal, Quebec
BioLargo appoints accomplished business executives Linda Park and Christina Bray to its board of directors
Both new board members have a background, education, and corporate experience that make them an ideal fit to advance BioLargo's core organizational goals, and its vision to "make life better" through its cleantech products and services.
BioLargo eyeing commercial opportunities ahead as it sets new quarterly revenue record
The cleantech group said it generated about $1.5 million in the three months to September 30 - a 13% increase compared to Q2 this year, and a 111% increase on Q3, 2021
Archive
Today's Market View - BioLargo Inc., and more...
SP Angel . Morning View . Tuesday 18 10 22Metals prices continue to slide as China doubles down on Zero-Covid strategyMiFID II exempt information – see disclaimer below Private Zambian copper exploration opportunityWe are looking for invest
BioLargo signs deal with Product Recovery Management to sell and distribute its water treatment systems
The channel partner agreement grants North Carolina-based PRM a license to sell and distribute BioLargo's water and wastewater treatment technologies, including but not limited to the Aqueous Electrostatic Concentrator
BioLargo sees 2Q revenue soar thanks to its environmental and engineering divisions
For the period ended June 30, 2022, the Westminster, California-based engineering and cleantech solution company, reported consolidated revenue of $1.32 million
BioLargo secures first PFAS mitigation customer and inks new channel partner for remediation
The cleantech technologies provider said the customer contract is for the first phase of what is expected to be a multi-phase comprehensive per- and polyfluoroalkyl substances (PFAS) remediation project
BioLargo sets quarterly revenue record; CEO Dennis Calvert says more quarterly records to come
The company generated approximately $1.3 million in revenue during the second quarter of 2022, a 37% increase from the first quarter of 2022, and a 185% increase from the second quarter of 2021
BioLargo says Ultra Safe Nuclear has hired it to help develop first prototype fuel production systems for new MMR reactor
Ultra Safe Nuclear has invented a fourth-generation modular nuclear reactor, which can deliver safe, zero-carbon, cost-effective energy anywhere
BioLargo Inc announces it achieved record 1Q revenue as its subsidiary ONM Environmental reports its first profitable quarter
“After investing years and millions of dollars into R&D for our innovative technologies, in this quarter we generated record revenues, our subsidiary ONM Environmental turned an operating profit, and our engineering subsidiary ended the qua
BioLargo sees preliminary 1Q revenue jump by 60% thanks to ONM Environmental and its engineering division
For the period ended March 31, 2022, the California-based group, which develops sustainable cleantech technologies and is a full-service environmental engineering company, reported revenue of $900,000
BioLargo says 2021 revenue increased year-over-year as its cleantech and engineering solutions advanced
Consolidated revenue for the year ended December 31, 2021, was $2,531,000, which was a 4% increase over 2020
BioLargo says its three current projects are 'major growth catalysts'
"We are making steady progress towards commercialization of our water treatment systems and have the benefit of working with experienced channel partners to get there,” said Calvert
BioLargo says its Aqueous Electrostatic Concentrator eliminates multiple PFAS compounds in testing with client water
BLEST’s Aqueous Electrostatic Concentrator was effective at functionally eliminating a toxic soup of PFAS from water provided by a large municipality in Southern California
BioLargo begins next step in preparing Garratt-Callahan minimal liquid discharge system for commercial launch
The new wastewater treatment system is based on Garratt-Callahan's minimal liquid discharge (MLD) technology, which reduces the volume of wastewater discharge from industrial facilities, saving customers disposal fees while reducing strain
BioLargo signs manufacturer's representative agreement with ICS for its water treatment technologies
Under the agreement, ICS has been tasked to sell BioLargo’s two proprietary water treatment technologies
BioLargo inks strategic partnership with Ikigai Holdings to launch its new pet odor control product, POOPH
BioLargo CEO Dennis P. Calvert said Ikigai will purchase "the POOPH products from us, and in addition, we receive a royalty on sales"
BioLargo reports rising consolidated 3Q revenue on strong engineering division growth
For the three months ended September 30, 2021, the company generated $712,000, a 7% year-over-year increase
BioLargo says peer-reviewed paper confirms “unprecedented performance” of its AOS water treatment technology
The company noted the article confirms that its Advanced Oxidation System (AOS) generates highly energetic iodine molecules likely responsible for the technology's elevated disinfection efficacy
BioLargo boss says company is close to unlocking the potential of its technologies in wide-ranging update
In a wide-ranging letter to stockholders, CEO Dennis Calvert also noted that the company had the financing in place to meet its short-term needs
BioLargo introduces new PFAS testing and treatment system selection program
The program is described as offering peace of mind and proof of concept to customers who need PFAS water treatment solutions in the face of an uncertain and rapidly evolving technological and regulatory landscape
BioLargo sees an 11% year-over-year rise in consolidated revenue
The company's fiscal overview noted an 11% increase in consolidated revenue which rose to $464,000, compared to the second quarter of 2020
BioLargo praises US Government’s PFAS action plan; enters deal to treat contaminated water in Southern California
The company's AEC technology has been proven to remove more than 99% of PFAS from contaminated water
BioLargo says engineering subsidiary on a hot streak with new contract awards
The wins are expected to increase operating cash flow, which will support its plans for top-line revenue growth and efforts to commercialize several of its patented environmental technologies
BioLargo says peer-reviewed scientific paper confirms safety of water treated by its Advanced Oxidation System
The study shows the company's Advanced Oxidation System (AOS) generates less disinfection by-products than common wastewater treatment technologies
BioLargo strengthens balance sheet by eliminating nearly all of its convertible debt
It recently paid off $406,000 in convertible debt that would have come due in August 2021 through cash and equity
BioLargo reports improving balance sheet as it plans first commercial pilots for its PFAS-treatment technology
'We are now in a strong cash position, have reliable financing resources, and have retired all but $456,000 of our convertible debt,' says CEO Dennis Calvert
BioLargo says PFAS toxic chemicals solution hits major technical milestone, paving way for commercial trials
The company has re-designed the Aqueous Electrostatic Concentrator's electrical configuration, improving its operating and maintenance costs
BioLargo sees 2020 revenue rise 31% as its cleantech technologies gain commercial traction
BioLargo Engineering scores big contracts with industrial clients, with a backlog of over $2 million in projects over the next 12-to-18 months
BioLargo eliminates $650,000 in debt as part of strategic plan to slash costly interest expenses
Aside from the debt carried by its partially owned subsidiary Clyra Medical, only SBA loans and fixed-price convertible debt remain on BioLargo's balance sheet
BioLargo set to answer US President Joe Biden’s call to remove per and polyfluoroalkyl chemicals (PFAS) from drinking water
The company said its AEC PFAS water treatment solution produces far less PFAS-laden waste than traditional carbon-based technologies
BioLargo says subsidiary ONM Environmental acquired deodorizing and sanitizing trash receptacle spray technology called EcoMist
ONM plans to test-market the product directly with its major solid waste handling customers by packaging it with its popular odor and volatile organic compounds control product CupriDyne Clean
BioLargo teams up with Garratt-Callahan to co-create and develop a wastewater treatment product
The developer of cutting-edge environmental technologies and a full-service engineering firm said a mutual concern for the environment and the care and conservation of water makes the collaboration between the two companies a "symbiotic mat
BioLargo preparing for commercial trials of its AEC water technology after successful lab tests
Per- and polyfluoroalkyl substances (PFAS) are a class of man-made chemical contaminants found in various products such as cookware and electronics
BioLargo estimates a 31% surge in 2020 full-year revenue driven by product breakthroughs
For its fourth quarter ended December 31, 2020, the California-based company reported revenue of $900,000, a 36% jump, compared to the same quarter in 2019
Archive
Hear from executives leading three rising star companies at the Proactive's latest virtual investor forum on January 26
Join BioLargo, Phunware and Recruiter.com at the Proactive One2One Investor Forum on January 26
BioLargo: Meet the engineering company dedicated to sustainability in water, air and health
Join BioLargo, Phunware and Recruiter.com at the Proactive One2One Investor Forum on January 26
BioLargo completes making its first-ever, commercial-scale AOS water treatment unit for a wastewater treatment pilot project near Montreal
The pilot will provide real-time data of AOS performance in a municipal wastewater stream
BioLargo receives further validation for its AOS water disinfection system with commercial-scale projects set to begin this year
BioLargo believes its two “significant” commercial-scale AOS projects set to start in 2021 will ultimately lead to significant market adoption
BioLargo subsidiary gets grant money to design wastewater treatment project at Alberta poultry farm
The system will treat the wastewater produced by farming operations and convert it to reusable water, saving the farm money and reducing its environmental impact
BioLargo sponsors Nightingale 2030 Resilience Fund’s special online play 'What Would Flo Do?'
A percentage of profits from the sales of the company's Clyraguard antimicrobial disinfecting spray is going to support the Nightingale 2030 Resilience Fund
Archive
NA Proactive news snapshot: Benchmark Metals, Metalla Royalty & Streaming, NetCents Technology, Codebase Ventures UPDATE...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
BioLargo says current fourth-quarter revenues of approximately $750,000 will result in new quarterly and annual records for the company
In addition to setting revenue records, BioLargo also significantly reduced its debt obligations during the year
BioLargo says subsidiary ONM Environmental installed CupriDyne Clean air quality control systems at two landfills in California
CupriDyne Clean eliminates odor-causing and volatile organic compounds rather than masking them
BioLargo reports record 3Q revenue; says its water technologies are ready for commercialization
The company believes the first sales are pending for its two water technologies
BioLargo says BLEST subsidiary awarded contract to assist in the reconfiguration of Regenerative Thermal Oxidizer (RTO) systems at a large chemicals plant
The contract is expected to execute with a series of milestones through mid-2021, with anticipated scope expanding the contract period to at least 24 months and over $500,000 in total revenue
BioLargo says subsidiary Clyra Medical's disinfectant spray Clyraguard now available on Amazon.com
The subsidiary also has a partnership with Powerplay Retail to roll-out Clyraguard to major retailers nationwide
BioLargo sees 3Q revenue rise by 60% with business development efforts paying off
For the period ended September 30, 2020, the Westminster, California-based company, reported revenue of $650,000
BioLargo Inc subsidiary Clyra Medical's COVID-19-inactivating spray Clyraguard now available to the public
Clyraguard is a hospital-grade, FDA-registered germicide that can be easily applied on the go, without having to remove a mask
BioLargo's CupriDyne-based disinfectant kills the coronavirus in 10 minutes, study says
The results were achieved in a third-party study of a modified CupriDyne formula at the Galveston National Laboratory at the University of Texas Medical Branch
BioLargo unveils first municipal wastewater trial of water treatment technology
The trial will take place at a treatment plant near Montréal in Québec and will be supervised by experts from the Centre des Technologies de L'Eau
Archive
NA Proactive news snapshot: NexTech AR, DGTL Holdings, Power Ore, Gevo UPDATE …
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
BioLargo sees demand increasing for its Clyraguard Personal Protection Spray that decontaminates personal protection equipment
The company expects substantial revenue increases from product sales of the spray in the third quarter of 2020
BioLargo says July sales doubled its monthly average thanks to new personal disinfectant
Its subsidiary Clyra Medical recently introduced Clyraguard Personal Protection Spray, an FDA-registered disinfectant for personal protective equipment
BioLargo says subsidiary manufactures first AEC prototype to eliminate PFAS contaminants from water
AEC is being tested and will be installed on-site for its first field pilot in the coming months
BioLargo subsidiary Clyra Medical names new CRO and business development head
Shawn Dougherty will serve as chief revenue officer with John Sirpilla taking over as chief business development officer
BioLargo says subsidiary's Clyraguard protective spray inactivates SARS-CoV-2 virus in lab tests
Clyraguard is a clear personal spray designed to help frontline healthcare workers prevent cross-contamination of their personal protective equipment
BioLargo Inc clocked record revenue in 2019 driven by new channel partnerships, commercial milestones
For the year ended December 31, 2019, the environmental engineering company posted a 37% rise in revenue to more than $1.8 million
BioLargo CEO Dennis P. Calvert says company still 'forging ahead' despite the coronavirus pandemic
He said BioLargo's major clients are municipalities, landfills and air force bases and the company continues to support them
BioLargo closes JV deal with South Korea’s BKT for CupriDyne Clean products
The newly formed venture will manufacture and support the distribution of odor and volatile organic compound control products
BioLargo unveils commercial design for Advanced Oxidation System for treating polluted water
It eliminates bacteria, viruses, and pathogenic organisms, and can reduce pharmaceuticals and antibiotics more effectively than standard systems used to treat wastewater
BioLargo Water launches crowdfunding campaign to get its wastewater treatment technology into poultry processing markets
The company's Advanced Oxidation System eliminates bacteria, viruses, and other pathogenic organisms from wastewater
BioLargo sets up JV with South Korea’s BKT and Tomorrow Water for CupriDyne Clean products
An annual dividend of $2 million will be paid to BioLargo to secure exclusive rights in perpetuity
BioLargo engineers top-notch, low-cost answer to PFAS water contamination problem
The firm’s Aqueous Electrostatic Concentrator device is effective in eliminating a toxic soup of PFAS chemicals from water
BioLargo’s subsidiary tackles PFAS toxic chemicals head-on with new treatment technology
BLEST’s Aqueous Electrostatic Concentrator was effective at eliminating a toxic soup of PFAS from water
BioLargo taps water industry veteran Tonya Chandler as director of strategic marketing and business development
She will focus on advancing sales and marketing BioLargo’s patented products and engineering services for water-related industries
BioLargo ends 2019 with record revenue; expects at least 2X growth in 2020
Revenue for the calendar year grew 37% year-over-year to more than $1.8 million
BioLargo's CupriDyne Clean effectively knocks out hydrogen sulfide, third-party lab tests show
The company said the independent tests proved CupriDyne Clean is eliminating, rather than masking toxic air contaminant odors